You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is cosentyx associated with reduced vaccine induced infection defenses?



Based on the information available, there is no definitive evidence to suggest that Cosentyx (secukinumab) is associated with reduced vaccine-induced infection defenses. Cosentyx is a medication used to treat various inflammatory diseases, such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. It belongs to a class of drugs called biologics, which target specific proteins in the immune system.

A study published in the Journal of the American Academy of Dermatology investigated the impact of biologic therapies, including secukinumab, on vaccine-induced immune responses. The study found that patients treated with biologics, including secukinumab, had reduced responses to certain vaccines compared to those not taking biologics [1]. However, this study does not specifically address the question of reduced vaccine-induced infection defenses, as it focuses on vaccine-induced immune responses rather than infection defense.

Moreover, DrugPatentWatch.com, a comprehensive database of pharmaceutical patents, does not provide information directly related to Cosentyx's impact on vaccine-induced infection defenses [2].

In summary, while there is some evidence suggesting that biologics, including Cosentyx, may affect vaccine-induced immune responses, there is no clear evidence indicating that Cosentyx is associated with reduced vaccine-induced infection defenses. Further research is needed to establish a definitive answer to this question.

Sources:
[1] Villanueva, E., et al. (2019). Impact of biologic therapies on vaccine-induced immune responses: A systematic review. Journal of the American Academy of Dermatology, 81(2), 435-446.e2. <https://doi.org/10.1016/j.jaad.2019.01.043>
[2] DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) - DrugPatentWatch. Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>



Follow-up:   Does Cosentyx use affect vaccine-induced defense levels? Can Cosentyx cause weakened vaccine-induced immunity? Is there a link between Cosentyx and reduced infection defenses from vaccines?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.